These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35042543)

  • 1. The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study.
    Ghaed-Sharaf M; Hariri S; Poustchi H; Nourollahi M; Khani S; Taherifard E; Mohammadi Z; Hadipour M; Sabaei R; Gandomkar A; Malekzadeh F; Vardanjani HM
    BMC Psychol; 2022 Jan; 10(1):12. PubMed ID: 35042543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran.
    Mohsenzadeh P; Ardekani A; Poustchi H; Mohammadi Z; Abdipour Mehrian SR; Bazrafshan Drissi H; Rahimian Z; Taherifard E; Nabavizadeh A; Kamalipour A; Mesgarpour B; Malekzadeh F; Molavi Vardanjani H
    BMC Cardiovasc Disord; 2022 Oct; 22(1):435. PubMed ID: 36203125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy and pattern of medication use among patients with gastroesophageal reflux disease: results from Pars Cohort study.
    Ghamar-Shooshtari A; Rahimian Z; Poustchi H; Mohammadi Z; Mesgarpour B; Akbari M; Kamalipour A; Abdipour-Mehrian SR; Hashemi ES; Zare P; Lankarani KB; Malekzadeh R; Malekzadeh F; Vardanjani HM
    BMC Gastroenterol; 2023 Dec; 23(1):439. PubMed ID: 38097949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort Study.
    Akbari MR; Kamalipour A; Pakroo M; Mesgarpour B; Poustchi H; Mohammadi Z; Gandomkar A; Molavi Vardanjani H
    Arch Iran Med; 2023 Mar; 26(3):156-165. PubMed ID: 37543938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy and medication usage patterns in hypertensive patients: Findings from the Pars Cohort Study.
    Zare P; Poustchi H; Mohammadi Z; Mesgarpour B; Akbari M; Kamalipour A; Abdipour-Mehrian SR; Hashemi ES; Ghamar-Shooshtari A; Hosseini SA; Malekzadeh R; Bazrafshan Drissi H; Malekzadeh F; Molavi Vardanjani H
    Res Social Adm Pharm; 2024 Nov; 20(11):1038-1046. PubMed ID: 39098543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based prevalence of polypharmacy and patterns of medication use in southwestern Iran: A cross-sectional study.
    Taherifard E; Mohammadi Z; Molavi Vardanjani H; Pakroo M; Emaminia M; Rahimi Z; Danehchin L; Abolnezhadian F; Malihi R; Paridar Y; Hariri S; Hashemi F; Cheraghian B; Mard A; Shayesteh AA; Poustchi H
    Pharmacoepidemiol Drug Saf; 2022 May; 31(5):592-603. PubMed ID: 35187734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Pattern, and Correlates of Polypharmacy among Iranian Type II Diabetic Patients: Results from Pars Cohort Study.
    Azadi M; Kamalipour A; Molavi Vardanjani H; Poustchi H; Taherifard E; Sharifi MH; Salehi A; Mohammadi Z
    Arch Iran Med; 2021 Sep; 24(9):657-664. PubMed ID: 34816680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of polypharmacy among elderly Thais with depressive and anxiety disorders: findings from the DAS study.
    Wongpakaran N; Wongpakaran T; Sirirak T; Jenraumjit R; Jiraniramai S; Lerttrakarnnon P
    BMC Geriatr; 2018 Dec; 18(1):309. PubMed ID: 30541459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with polypharmacy in the older people: 2006-2014.
    Carmona-Torres JM; Cobo-Cuenca AI; Recio-Andrade B; Laredo-Aguilera JA; Martins MM; Rodríguez-Borrego MA
    J Clin Nurs; 2018 Aug; 27(15-16):2942-2952. PubMed ID: 29603814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-practice variation in polypharmacy prevalence amongst older patients in primary care.
    Sinnige J; Braspenning JC; Schellevis FG; Hek K; Stirbu I; Westert GP; Korevaar JC
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1033-41. PubMed ID: 27133740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran.
    Amini A; Taherifard E; Akbari M; Taherifard E; Dehdari Ebrahimi N; Rajabi MR; Zamani F; Rekabpour SJ; Jafaraghaie R; Hassanzadeh J; Molavi Vardanjani H
    Expert Rev Hematol; 2024 Sep; 17(9):643-650. PubMed ID: 39061121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study.
    Wright RM; Sloane R; Pieper CF; Ruby-Scelsi C; Twersky J; Schmader KE; Hanlon JT
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):271-80. PubMed ID: 19948303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and determinants of polypharmacy at age 69: a British birth cohort study.
    Rawle MJ; Richards M; Davis D; Kuh D
    BMC Geriatr; 2018 May; 18(1):118. PubMed ID: 29769020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
    Porter B; Arthur A; Savva GM
    BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and multiple sclerosis: A population-based study.
    Chertcoff A; Ng HS; Zhu F; Zhao Y; Tremlett H
    Mult Scler; 2023 Jan; 29(1):107-118. PubMed ID: 36301629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy and health beliefs in older outpatients.
    Rossi MI; Young A; Maher R; Rodriguez KL; Appelt CJ; Perera S; Hajjar ER; Hanlon JT
    Am J Geriatr Pharmacother; 2007 Dec; 5(4):317-23. PubMed ID: 18179989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional evaluation of the prevalence and detection of predictors of polypharmacy amongst adult in Spain.
    Niclós G; Olivar T; Rodilla V
    Int J Pharm Pract; 2018 Jun; 26(3):242-249. PubMed ID: 28795462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
    Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014.
    Fontanella CA; Hiance-Steelesmith DL; Guirgis H; Campo JV
    Psychiatr Serv; 2018 Sep; 69(9):1015-1020. PubMed ID: 29962308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.